Impaired glucose tolerance and cardiovascular disease: The possible role of post-prandial hyperglycemia

被引:89
作者
Ceriello, A [1 ]
机构
[1] Univ Udine, Chair Internal Med, Dept Pathol & Med Expt & Clin, I-33100 Udine, Italy
关键词
D O I
10.1016/j.ahj.2003.11.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There is increasing evidence that the post-prandial state is an important contributing factor in the development of atherosclerosis. In subjects with impaired glucose tolerance, whereas fasting glycemia is in reference range, the post-prandial phase is characterized by a rapid and large increase in blood glucose levels. The possibility that this post-prandial "hyperglycemic spike" may be relevant to the development of cardiovascular disease in these subjects has received recently much attention. The oral glucose tolerance test, although highly non-physiological, has been used largely as model of the post-prandial state, and epidemiological studies have shown that impaired oral glucose tolerance is associated with an increased risk of cardiovascular disease, because the glycemia level after 2 hours of the glucose challenge is a direct and independent risk factor. Most of the cardiovascular risk factors are modified in the post-prandial phase and are directly affected by an acute increase of glycemia. The mechanisms through which acute hyperglycemia exerts its effects may be identified in the production of free radicals, which favours the development of an endothelial dysfunction, a prothrombotic and proinflammatory condition. Future studies may evaluate whether correcting the post-prandial hyperglycemia in the impaired glucose tolerance state can form part of the strategy for the prevention and management of cardiovascular diseases in these subjects.
引用
收藏
页码:803 / 807
页数:5
相关论文
共 70 条
  • [1] [Anonymous], WHO TECHN REP SER
  • [2] High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men -: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study
    Balkau, B
    Shipley, M
    Jarrett, RJ
    Pyörälä, K
    Pyörälä, M
    Forhan, A
    Eschwège, E
    [J]. DIABETES CARE, 1998, 21 (03) : 360 - 367
  • [3] Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
  • [4] HYPERGLYCEMIA AND PROGNOSIS OF ACUTE MYOCARDIAL-INFARCTION IN PATIENTS WITHOUT DIABETES-MELLITUS
    BELLODI, G
    MANICARDI, V
    MALAVASI, V
    VENERI, L
    BERNINI, G
    BOSSINI, P
    DISTEFANO, S
    MAGNANINI, G
    MURATORI, L
    ROSSI, G
    ZUARINI, A
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (14) : 885 - 888
  • [5] TOPICAL HYPERGLYCEMIA RAPIDLY SUPPRESSES EDRF-MEDIATED VASODILATION OF NORMAL RAT ARTERIOLES
    BOHLEN, HG
    LASH, JM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (01): : H219 - H225
  • [6] IGT and IFG. Time for revision?
    Borch-Johnsen, K
    [J]. DIABETIC MEDICINE, 2002, 19 (09) : 707 - 707
  • [7] Borch-Johnsen K, 1999, LANCET, V354, P617
  • [8] Biochemistry and molecular cell biology of diabetic complications
    Brownlee, M
    [J]. NATURE, 2001, 414 (6865) : 813 - 820
  • [9] Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
    Capes, SE
    Hunt, D
    Malmberg, K
    Gerstein, HC
    [J]. LANCET, 2000, 355 (9206) : 773 - 778
  • [10] Ceriello A, 1997, DIABETIC MED, V14, pS45, DOI 10.1002/(SICI)1096-9136(199708)14:3+<S45::AID-DIA444>3.3.CO